Trial Profile
A Phase II/III, Randomized, Double-Blind, Comparative Trial Of Azithromycin Plus Chloroquine Versus Mefloquine For The Treatment Of Uncomplicated Plasmodium Falciparum Malaria In Africa
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Chloroquine/azithromycin (Primary) ; Mefloquine
- Indications Falciparum malaria
- Focus Therapeutic Use
- Sponsors Pfizer
- 06 Nov 2014 New trial record